Galafold 123 MG
Ended Awarded
- Contract number
- 36C24525N0126
- Awardee
-
Amicus Therapeutics US, LLC UEI KLJFGENKMD89 Part of Amicus Therapeutics, Inc.
- Awarding agency
-
Veterans Integrated Service Network 5
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $21,089
Award facts
- Contract value 100% obligated
- $21,089.47 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Philadelphia, PA 19104, USA
Award details come from SAM.gov/FPDS.
About this award
This federal contract award is for the delivery of the pharmaceutical product Galafold (migalastat) 123 mg to the Department of Veterans Affairs (VA) Veterans Integrated Service Network 5 (VISN 5). The $21,089.47 firm-fixed-price delivery order was awarded to Amicus Therapeutics US, LLC, a subsidiary of the parent company Amicus Therapeutics, Inc.
Amicus Therapeutics US, LLC holds a Federal Supply Schedule (FSS) contract with the VA to supply specialized medications like Galafold, which is used to treat Fabry disease. This multiple-award, firm-fixed-price FSS contract has a ceiling value of $13,024,630 and runs through August 2029, providing a mechanism for VA healthcare facilities across the country to efficiently procure these critical pharmaceutical products. The current $21,089.47 delivery order supports the VA's mission to ensure continuous access to treatments for rare diseases like Fabry disease for veterans in the VISN 5 region, which includes Philadelphia, Pennsylvania. No set-aside designation was applied to this contract award.
Quick answers
Who was awarded contract 36C24525N0126?
36C24525N0126 was awarded to Amicus Therapeutics US, LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on October 15, 2024.
How much is contract 36C24525N0126 worth?
The government has obligated $21,089 on 36C24525N0126.
Is contract 36C24525N0126 an order under another contract?
Yes. 36C24525N0126 is a delivery order under 36F79724D0185, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C24525N0126 competed?
The extent of competition for 36C24525N0126 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award